SIRT1 and peripheral arterial disease: To elucidate this, we used endothelial‐specific SIRT1 knockout mice treated with T0901317 to investigate the interaction between SIRT1 and LXR and evaluate the potential effects of LXR agonist treatment on diabetic PAD.